SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEbiquity Regulatory News (EBQ)

Share Price Information for Ebiquity (EBQ)

Share Price is delayed by 15 minutes
Get Live Data
10.75    0.00 (0.00%)
Bid:
10.50
Ask:
11.00
Spread: 0.50 (4.762%)
Market Cap: £14.94m
EBQ Live PriceLast checked at - London Stock Exchange

Intraday Ebiquity Share Chart

Awards extension

21 Apr 2017 15:00

RNS Number : 0286D
Ebiquity PLC
21 April 2017
 

Ebiquity Plc

("the Company")

 

Awards extension

 

Ebiquity plc announces that the lapse date of certain share incentivisation awards (the "Awards", as defined below) made to Nick Manning (Chief Strategy Officer) and Michael Greenlees (formerly Chief Executive Officer who ceased to be a Director on 30 April 2016) has today been extended from 30 April 2017 to 30 April 2020, in order to retain flexibility for the Company. The Awards were originally due to lapse on 30 April 2015 and, as announced on 16 March 2015, were extended to 30 April 2017. The performance criteria relating to the Awards were satisfied in full prior to 30 April 2015 and the Awards are already fully exercisable.

 

In April 2010, Nick Manning was awarded share options over up to 1,800,000 ordinary shares of 25 pence each in the capital of the Company ("Ordinary Shares") and Michael Greenlees was awarded share options over up to 2,400,000 Ordinary Shares (together the "Awards"). An employee benefit trust was established and issued with 4,200,000 Ordinary Shares to satisfy exercise of the Awards.

 

Following this extension, Nick Manning's beneficial holdings in Ordinary Shares remains unchanged as he is interested in 230,000 Ordinary Shares (representing 0.3% of the Company's issued ordinary share capital) and holds options over 2,543,490 Ordinary Shares (including the Awards).

 

21 April 2017

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

 

Nicholas Vincent Manning

Reason for the notification

 

a)

Position/status:

 

Chief Strategy Officer

b)

Initial notification/Amendment:

 

Initial notification

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

Name:

 

Ebiquity plc

b)

LEI:

 

2138004YRTDJ7FJSWF20

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

Description of the financial instrument, type of instrument:

Identification code:

 

Options over ordinary shares of £0.25 each

GB0004126057

b)

Nature of the transaction:

Extension of the lapse date of the options from 30 April 2017 to 30 April 2020.

c)

Price(s) and volume(s):

 

 

Price(s)

Volume(s)

N/A

1,800,000

d)

Aggregated information:

· Aggregated volume:

· Price:

· average price of the aggregated transactions.

· 1,800,000

· N/A

e)

Date of the transaction:

21 April 2017

 

f)

Place of the transaction:

Outside trading venue

 

 

 

Enquiries:

Ebiquity plc

Michael Karg (CEO)

Andrew Noble (CFO)

 

Instinctif Partners

Matthew Smallwood

Guy Scarborough

 

020 7650 9600

 

 

 

020 7457 2020

Numis Securities Limited

Nick Westlake Oliver Hardy (NOMAD)

Toby Adcock (Corporate Broker)

020 7260 1000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPGUPCCUPMGWG
Date   Source Headline
25th Jun 20187:15 amRNSStatement re CMA Phase 2 referral
15th Jun 20187:00 amRNSPartnership with Snapchat to enhance measurement
13th Jun 20187:05 amRNSStatement re CMA review of disposal
1st Jun 20189:15 amRNSTotal Voting Rights
18th May 201812:20 pmRNSHolding(s) in Company
9th May 201812:11 pmRNSAGM Resolutions Passed
9th May 20187:00 amRNSIssue of Shares
1st May 20181:10 pmRNSHolding(s) in Company
27th Apr 20187:00 amRNSDirector/PDMR Shareholding
13th Apr 20187:00 amRNSAnnual Report
12th Apr 20182:15 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:05 pmRNSHolding(s) in Company
21st Mar 20183:00 pmRNSDividend Declaration
21st Mar 20187:00 amRNSFinal Results
1st Mar 20187:00 amRNSTotal Voting Rights
27th Feb 20187:00 amRNSDirectorate Change
19th Feb 20187:00 amRNSIssue of Shares
13th Feb 20182:00 pmRNSDirector/PDMR dealing and grant of options
13th Feb 20187:00 amRNS£26m disposal and pre-close trading statement
2nd Jan 20184:45 pmRNSTotal Voting Rights
19th Dec 20177:00 amRNSDirectorate Change
28th Nov 201710:15 amRNSHolding(s) in Company
17th Nov 201712:01 pmRNSIssue of Shares
8th Nov 20173:00 pmRNSIssue of Shares
26th Sep 20177:00 amRNSInterim Results
19th Sep 20175:50 pmRNSHolding(s) in Company
31st Aug 20172:45 pmRNSTotal Voting Rights
24th Aug 20177:00 amRNSIssue of Shares
21st Aug 20177:00 amRNSIssue of Shares
17th Aug 20178:52 amRNSIssue of Shares
8th Aug 20177:00 amRNSExercise of Share Options and dealing by PDMR
3rd Aug 20177:00 amRNSInterim trading statement
11th Jul 20177:00 amRNSEbiquity Launches Total View Attribution service
4th Jul 20177:00 amRNSEbiquity Launches Media Transparency Score tool
31st May 20171:00 pmRNSTotal Voting Rights
11th May 20175:05 pmRNSExercise of Share Options
10th May 201711:16 amRNSResult of AGM
2nd May 201711:05 amRNSDirector/PDMR Shareholding
21st Apr 20173:00 pmRNSAwards extension
20th Apr 20177:00 amRNSEbiquity launches 'Portfolio Digital' in the UK
18th Apr 201710:05 amRNSAnnual Report
29th Mar 201711:02 amRNSDividend Declaration
28th Mar 20177:00 amRNSFinal Results
10th Mar 20173:30 pmRNSHolding(s) in Company
26th Jan 20177:00 amRNSPre-close trading statement
2nd Dec 201612:15 pmRNSDeferred Consideration/Issue of Ordinary Shares
11th Nov 20162:48 pmRNSHolding(s) in Company
14th Oct 201612:30 pmRNSRe Directorate
6th Oct 20167:00 amRNSLaunch of Strategic Media Consultancy service
28th Sep 20167:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.